Vimizim ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

vimizim

biomarin international limited - recombinant human n-acetylgalactosamine-6-sulfatase - mucopolysaccharidose iv - andre alimentary tract and metabolism produkter, - vimizim er indiceret til behandling af mucopolysaccharidose, type iva (morquio a syndrome, mps iva) hos patienter i alle aldre.